Clinical observations show the sermorelin glutathione stack produces subjective improvements in sleep and energy within 24 weeks and measurable lean mass gains of 24% by 12 weeks
The aim of this study is to address the knowledge gap regarding the effects of GLP1RAs on human reproduction, with special focus on the endometrium
Tirzepatide, the dual GIP and GLP-1 agonist, sits a clear step above semaglutide on weight loss and has added indications of its own, including obstructive sleep apnea
In addition, there are other emerging antifungal treatments, they include monoclonal antibodies (such as C3.1) and immunomodulators (such as TLR9 agonists)
In general, GHK-Cu has demonstrated good tolerability in research settings, particularly in topical applications
Lancet, 376(9765), 14921500